Tobias Ruck Selected Research

Deglutition Disorders (Dysphagia)

1/2021	Detecting myasthenia gravis as a cause of unclear dysphagia with an endoscopic tensilon test.
7/2020	The Impact of Dysphagia in Myositis: A Systematic Review and Meta-Analysis.
1/2019	Substance P Saliva Reduction Predicts Pharyngeal Dysphagia in Parkinson's Disease.
1/2019	Intubation, tracheostomy, and decannulation in patients with Guillain-Barré-syndrome-does dysphagia matter?
1/2019	Dysphagia as Isolated Manifestation of Jo-1 Associated Myositis?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tobias Ruck Research Topics

Disease

38	Multiple Sclerosis 01/2024 - 07/2014
14	Relapsing-Remitting Multiple Sclerosis 01/2023 - 07/2015
11	Myasthenia Gravis 04/2024 - 01/2019
10	Neuroinflammatory Diseases 01/2023 - 07/2014
8	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 11/2022 - 03/2011
7	Myositis (Idiopathic Inflammatory Myopathies) 01/2024 - 08/2010
7	Inflammation (Inflammations) 01/2023 - 08/2014
5	Disease Progression 03/2024 - 01/2022
5	Infections 08/2022 - 07/2018
5	Deglutition Disorders (Dysphagia) 01/2021 - 01/2019
4	Demyelinating Diseases (Demyelinating Disease) 01/2023 - 07/2014
4	Lymphopenia (Lymphocytopenia) 01/2023 - 01/2016
4	Encephalomyelitis (Myeloencephalitis) 11/2022 - 07/2014
3	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 10/2023 - 01/2022
3	Autoimmune Diseases (Autoimmune Disease) 01/2023 - 12/2018
3	COVID-19 01/2022 - 06/2020
2	Muscular Atrophy (Muscle Atrophy) 04/2024 - 08/2021
2	Muscle Weakness 03/2024 - 08/2021
2	Neuromuscular Diseases (Neuromuscular Disease) 01/2024 - 10/2023
2	Neoplasms (Cancer) 01/2024 - 07/2020
2	Polyneuropathies (Polyneuropathy) 10/2023 - 01/2022
2	Guillain-Barre Syndrome 10/2023 - 01/2019
2	Paralysis (Palsy) 10/2023 - 03/2011
2	Stroke (Strokes) 01/2023 - 01/2017
2	Inclusion Body Myositis 10/2022 - 01/2022
2	Dermatomyositis (Dermatopolymyositis) 10/2022 - 01/2021
2	Virus Diseases (Viral Diseases) 02/2022 - 01/2021
2	Urinary Tract Infections (Urinary Tract Infection) 01/2022 - 01/2020
2	Exanthema (Rash) 08/2021 - 01/2021
2	Rheumatoid Arthritis 05/2021 - 07/2015
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2021 - 09/2013
2	Cognitive Dysfunction 01/2017 - 01/2017
2	Polymyositis 12/2015 - 03/2015
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 05/2024
1	Experimental Autoimmune Myasthenia Gravis (Autoimmune Experimental Myasthenia Gravis) 03/2024
1	Myocarditis (Carditis) 01/2024
1	Cardiomyopathies (Cardiomyopathy) 06/2023
1	Muscular Dystrophies (Muscular Dystrophy) 06/2023
1	Myotonic Dystrophy (Dystrophia Myotonica) 06/2023
1	Fibrosis (Cirrhosis) 06/2023
1	Medically Unexplained Symptoms 01/2023
1	Human Influenza (Influenza) 01/2023
1	Gliosis 01/2023
1	Glioma (Gliomas) 01/2023
1	Chronic Progressive Multiple Sclerosis 11/2022
1	Muscular Diseases (Myopathy) 11/2022
1	Absence Epilepsy (Childhood Absence Epilepsy) 10/2022

Drug/Important Bio-Agent (IBA)

19	Alemtuzumab (Campath)FDA Link 01/2023 - 03/2015
8	Proteins (Proteins, Gene)FDA Link 04/2024 - 03/2011
7	AntibodiesIBA 03/2024 - 01/2016
6	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2019
6	AutoantibodiesIBA 01/2023 - 01/2019
6	Cladribine FDA LinkGeneric 01/2023 - 01/2021
4	Complement System Proteins (Complement)IBA 03/2024 - 10/2023
4	CytokinesIBA 10/2022 - 07/2014
3	Cholinergic ReceptorsIBA 04/2024 - 01/2019
3	Peptides (Polypeptides)IBA 10/2023 - 09/2013
3	Neuroprotective AgentsIBA 11/2022 - 01/2018
3	Ligases (Synthetase)IBA 10/2022 - 01/2021
3	ocrelizumabIBA 01/2022 - 01/2021
2	InterferonsIBA 03/2024 - 12/2018
2	Intravenous Immunoglobulins (IVIG)FDA Link 08/2023 - 08/2021
2	Ion Channels (Ion Channel)IBA 01/2023 - 05/2021
2	LigandsIBA 01/2023 - 12/2015
2	siponimodIBA 11/2022 - 11/2019
2	CuprizoneIBA 10/2022 - 01/2021
2	CalciumIBA 01/2022 - 12/2017
2	eculizumab FDA Link 01/2022 - 01/2021
2	Potassium Channels (Potassium Channel)IBA 01/2022 - 07/2015
2	Immunoglobulin G (IgG)IBA 06/2020 - 01/2020
2	Fingolimod Hydrochloride (FTY720)FDA Link 11/2019 - 01/2016
2	Monoclonal AntibodiesIBA 01/2019 - 07/2015
2	Natalizumab (Tysabri)FDA Link 01/2019 - 01/2017
2	Substance PIBA 01/2019 - 01/2017
1	nusinersenIBA 05/2024
1	ravulizumabIBA 04/2024
1	glucose-mannose-glucoseIBA 04/2024
1	Recombinant ProteinsIBA 03/2024
1	Immune Checkpoint InhibitorsIBA 01/2024
1	Myelin-Oligodendrocyte GlycoproteinIBA 10/2023
1	3' Untranslated Regions (3' UTR)IBA 06/2023
1	PeriostinIBA 06/2023
1	Sphingosine-1-Phosphate ReceptorsIBA 01/2023
1	AntigensIBA 01/2023
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2023
1	muskIBA 01/2023
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 01/2023
1	Leucine (L-Leucine)FDA Link 01/2023
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	NK Cell Lectin-Like Receptor Subfamily KIBA 01/2023
1	N,N- diethyl- 2- (2- (4- (2- fluoroethoxy)phenyl)- 5,7- dimethylpyrazolo(1,5- a)pyrimidin- 3- yl)acetamideIBA 01/2023
1	Hyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsIBA 10/2022
1	Tryptophan (L-Tryptophan)FDA Link 09/2022

Therapy/Procedure

22	Therapeutics 03/2024 - 07/2015
3	Immunotherapy 01/2022 - 06/2020
2	Blood Component Removal (Apheresis) 10/2019 - 01/2017
1	Activities of Daily Living (ADL) 04/2024
1	Thymectomy 06/2023
1	Duration of Therapy 01/2023